Cristina Llorente

Assistant Professor, Div. Gastroenterology, Dept. Medicine, UC San Diego
When
19th-20th Oct 2023
Where
San Diego, CA
The 2023 agenda is in production. Contact Mike Burden if you would like to contribute to this year’s meeting.
Be a part of a meeting that brings together academic, industry, and investment leaders to discuss cutting-edge developments in microbiome, skin & probiotic research. Together you will explore the challenges and opportunities in translating research toward commercialization, as well as learn how partnerships and collaborations can secure investment. In 2022 topics covered included gut health and disease, as well as the stunning advances being made in understanding the gut-brain axis. There are also dedicated tracks devoted to developments in Probiotics, Prebiotics, and Postbiotic research as well as personalized nutrition. There was expanded coverage of Women’s health, LBP, advances in HMO & infant health, and research in metabolic diseases
This world-renowned meeting provides a networking experience in which industry/academia collaborations are forged to translate research into clinical trials. Plus, the attendees have ample opportunity to review poster presentations and meet with exhibitors showcasing the latest products and services.
“The talks I went to had real content (data, innovative ideas, business impact)”
“I met people from all areas in this growing industry… academia, pharma and consumer products”
“Deeper understanding of product concepts – especially clinical relevance and application to health outcomes”
“Excellent speakers … a mix of research and business focussed talks”
Don’t forget your ticket also gives you access to the 5th Skin Microbiome & Cosmeceuticals Congress: USA
Some of last years speakers:
This program is designed to create a collaborative environment in which delegates can forge enduring relationships across the full range of microbiome and probiotic research. In 2022 we:
Find out about our sustainability values.
Skin Health & the Microbiome
Cosmetics and Commercial Strategy
Co-Founder & CEO, Microbiome Insights, Inc., Canada
Senior Director of Development, Arcaea
Chief Scientific Officer, Coty inc
Director, Microbiome Core Facility, UNC Chapel Hill
University of Washington
Assistant Professor, Div. Gastroenterology, Dept. Medicine, UC San Diego
Co-Chair, Advertising Disputes; Chair, Retail & Consumer Brands, Loeb & Loeb
Scientific and Regulatory Affairs, Project Manager, Morinaga
Associate Professor, Genetics and Genomic Sciences, Mount Sinai School of Medicine
,Associate Professor, Genomic Medicine and Infectious Diseases, JCVI
VP Scientific Affairs, Danone
Associate Director, Resiliency & Well-being Center, Program Director, Integrative Medicine (INTM) Executive Director, Office of INTM & Health, George Washington University School of Medicine and Health Sciences (SMHS)
Global Regulatory Strategy Lead, Health Dietary Supplements, IFF
VP Bioprocess & Development, Adiso Therapeutics
VP Research, Rise Therapeutics
Chief Medical Officer, Biotia; Research Assistant Professor at SUNY Downstate Health Sciences University
Assistant Professor of Biochemistry and Molecular Biology, The Pennsylvania State University
Business Development Manager, Bacthera
Chief Medical Officer, IFF
President and CEO, MatriSys Bioscience, Inc.
VP, Manufacturing, Rise Therapeutics
Scientist, Living Cellular Devices Platform, Wyss Institute at Harvard University
Technical Adviser, COSMAX
Associate Professor, Department of Nutrition and Integrative Physiology, University of Utah
Bioinformatics Scientist, Washington University, School of Medicine in St. Louis
CEO & Co-Founder, Mbiomics
Bioinformatician II, Diversigen
Director of Research and Innovation, NemaLife
CEO, Arome Science
Associate Professor, University of Toronto
CSO, Interface Bio
R&D Director, OptiBiotix Health PLC
Head of Clinical and Scientific Affairs, Burt’s Bees
Professor, University of Alberta, Canada
Co-Founder, AQABELA
Assistant Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Larry Weiss, CEO and Founder, Symbiome, USA
Founder and CEO, ImmuneBiotech AB
CSO, Clinical Microbiomics
Founder and CEO, OptiBiotix Health plc
Principal Investigator, Nationwide Children’s Hospital
President & CEO, AOBiome, USA
Professor, Department of Microbiology and Cell Science, University of Florida
Adam Baker, Director of Science, Human Health, Chr. Hansen
Group Leader, Complex Microbial Systems, National Institute of Standards and Technology (NIST), USA
Head of International Scientific Valorisation Luxury Division, L’Oréal Research & Innovation
CSO, Viome
Head of Clinical Development, Human Health innovation, Chr Hansen A/S, Denmark
Vice President, Human Metabolome Technologies
Co-Founder and Director of Advanced Technology, Azitra Inc.
Deputy Manager, Manda Fermentation Co. Ltd.
Senior R&D Manager, Lactobio A/S
Investment Advisor, Seventrue Partners
CEO, Phi Therapeutics, USA
Founder, VGAM Biosciences
Professor of Medicine, Mayo Clinic
Research Technical Leader, Life Science, Kimberly-Clark
Co-Founder/ Principal Scientist, BCD Bioscience
Head, Business Development, Biose Industrie
CEO, MRM Health
Chief Science Officer, Synbiotic Health
Co-Founder & CEO, Concerto Bioscience
Founder & CEO, ELSI Skin Health
Vice President, National Adverting Division, BBB National Programs
Founder & CEO, vermicon AG
Co-Founder/CEO, Sequential Skin
Head of R&D, Biose
Co-Founder & CEO, Microbiome Insights, Inc., Canada
Senior Director of Development, Arcaea
Chief Scientific Officer, Coty inc
Director, Microbiome Core Facility, UNC Chapel Hill
University of Washington
Assistant Professor, Div. Gastroenterology, Dept. Medicine, UC San Diego
Co-Chair, Advertising Disputes; Chair, Retail & Consumer Brands, Loeb & Loeb
Scientific and Regulatory Affairs, Project Manager, Morinaga
Associate Professor, Genetics and Genomic Sciences, Mount Sinai School of Medicine
,Associate Professor, Genomic Medicine and Infectious Diseases, JCVI
VP Scientific Affairs, Danone
Associate Director, Resiliency & Well-being Center, Program Director, Integrative Medicine (INTM) Executive Director, Office of INTM & Health, George Washington University School of Medicine and Health Sciences (SMHS)
Global Regulatory Strategy Lead, Health Dietary Supplements, IFF
VP Bioprocess & Development, Adiso Therapeutics
VP Research, Rise Therapeutics
Chief Medical Officer, Biotia; Research Assistant Professor at SUNY Downstate Health Sciences University
Assistant Professor of Biochemistry and Molecular Biology, The Pennsylvania State University
Business Development Manager, Bacthera
Chief Medical Officer, IFF
President and CEO, MatriSys Bioscience, Inc.
VP, Manufacturing, Rise Therapeutics
Scientist, Living Cellular Devices Platform, Wyss Institute at Harvard University
Technical Adviser, COSMAX
Associate Professor, Department of Nutrition and Integrative Physiology, University of Utah
Bioinformatics Scientist, Washington University, School of Medicine in St. Louis
CEO & Co-Founder, Mbiomics
Bioinformatician II, Diversigen
Director of Research and Innovation, NemaLife
CEO, Arome Science
Associate Professor, University of Toronto
CSO, Interface Bio
R&D Director, OptiBiotix Health PLC
Head of Clinical and Scientific Affairs, Burt’s Bees
Professor, University of Alberta, Canada
Co-Founder, AQABELA
Assistant Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Larry Weiss, CEO and Founder, Symbiome, USA
Founder and CEO, ImmuneBiotech AB
CSO, Clinical Microbiomics
Founder and CEO, OptiBiotix Health plc
Principal Investigator, Nationwide Children’s Hospital
President & CEO, AOBiome, USA
Professor, Department of Microbiology and Cell Science, University of Florida
Adam Baker, Director of Science, Human Health, Chr. Hansen
Group Leader, Complex Microbial Systems, National Institute of Standards and Technology (NIST), USA
Head of International Scientific Valorisation Luxury Division, L’Oréal Research & Innovation
CSO, Viome
Head of Clinical Development, Human Health innovation, Chr Hansen A/S, Denmark
Vice President, Human Metabolome Technologies
Co-Founder and Director of Advanced Technology, Azitra Inc.
Deputy Manager, Manda Fermentation Co. Ltd.
Senior R&D Manager, Lactobio A/S
Investment Advisor, Seventrue Partners
CEO, Phi Therapeutics, USA
Founder, VGAM Biosciences
Professor of Medicine, Mayo Clinic
Research Technical Leader, Life Science, Kimberly-Clark
Co-Founder/ Principal Scientist, BCD Bioscience
Head, Business Development, Biose Industrie
CEO, MRM Health
Chief Science Officer, Synbiotic Health
Co-Founder & CEO, Concerto Bioscience
Founder & CEO, ELSI Skin Health
Vice President, National Adverting Division, BBB National Programs
Founder & CEO, vermicon AG
Co-Founder/CEO, Sequential Skin
Head of R&D, Biose
2022 Microbiome & Probiotics R&D and Business Collaboration Forum USA | ||||
Room 1 | Room 2 | Room 3 | Room 4 | |
Day 1 | Gut Health & Disease (Gastro Disorders C.diff) |
Tool & Technologies | Probiotics & Prebiotics | Skin & cosmeceuticals |
Day 2 | Gut Health & Disease (Metabolic Disorders etc) |
LBP Manufacturing, Regulations, & Investment | Personalized Nutrition | Skin & cosmeceuticals |
Download the Meeting Agenda
Sign up to receive updates, news and speaker resources
Are you a start-up?
We have a number of special options for start-ups to be a part of the meeting. Contact Maria for the qualifying criteria.
3 for the price of 2 offer
Save with 5 passes Academic/Industry equivalent to $300/$1000 per person
Discount applied automatically at registration. If you do not know the names of your attendees use this form to secure the discounts.
Not applicable for solution provider companies or compatible with any other offers or discount code
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone or email [email protected]
Option 2 – Please complete the form below to pay online
“You are about to be a part of a great networking meeting. I can’t wait to welcome you in person.”
Steve Hambrook, CEO, Global Engage
Organisations offering services and/or business & technology solutions and business consultants please contact Gavin Hambrook to discuss participation at this meeting.
The fees shown are available to industry, academics and not for profit organisations.
To help us comply with GDPR (privacy regulations) please register using your official institution email address and not a personal email.
Are you a start-up? Contact [email protected] for innovative ways to join the meeting.
$499.00
$1,699.00
Standard registration for those not in the categories below
$1,899.00
Fee for representatives of organisations offering services and/or business & technology solutions and also to business consultants.
Poster presentation sessions will take place in breaks and alongside the other breakout sessions of the conference. Your presentation will be displayed in a dedicated area, with the other accepted posters from industry and academic presenters.
We also issue a poster eBook to all attendees containing your full abstract, and you can share your poster as a PDF after the meeting if you desire (optional).
Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, these are an excellent way to join the heart of this congress.
In order to present a poster at the forum, you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first-come-first-served basis (subject to checks and successful registration).
POSTER COMPETITION – CLOSING DATE October 7, 2022
Biose industrie is the worlds leading CDMO for Live Biotherapeutic products – Based in France we have over 30 different LBP programs being run out of our plant with well over a 100 different bacterial strains being developed or manaufactured at GMP level. 2022 will see us double our manufacturing volumes with even bigger expansion plnned in the next 3 years. Come and meet us at the event if you require support for your LBP program.
https://www.biose.com/
Clinical Microbiomics is a specialized microbiome research organisation providing scientific expertise worldwide. To support your product clinical development, we generate microbiome data of highest quality in our ISO17025 certified laboratory and with capabilities to comply to GCP standards for phase 1, 2 and 3 clinical trials. We use innovative analysis tools and concentrated scientific expertise ranging from microbial maturity in infants and treatment-response prediction using AI technologies to metabolomics generation and integration and engraftment analysis enabling clonal-level tracking of microbial therapeutics.
www.clinical-microbiomics.com/
×vermicon AG provides specific microbiological expertise and cultivation-independent methods for the identification, quantification and visualization of microorganisms directly at their site of action. By using FISH (Fluorescence In Situ Hybridization), Flow Cytometry and individually adapted solutions, vermicon enables a profound and holistic understanding of the human microbiome, supports the development and production of microbiome-based therapeutics, and enhances the development and quality control of probiotics. The company is GMP certified.
https://www.vermicon.com/microbiome
×Diversigen is a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR) focused on powering microbiome discovery through comprehensive services for sample processing, sequencing, and bioinformatic analysis. Diversigen, who has sequenced more than 225,000 microbial samples, offers the best analytical science available to accelerate microbiome discovery for academic, pharmaceutical, biotechnology, agricultural and environmental applications. From study design to sample processing, data generation, and full custom analysis we ensure you get the most out of your data.
×Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. Arranta offers the knowledge and resources necessary to help clients develop and manufacture promising new microbiome therapies with both process development and contract manufacturing for fermentation, lyophilization and encapsulation of Live Biotherapeutic Products (LBPs).
×Bacthera is a Danish/Swiss-based one-stop CDMO in the field of LBP’s, with the overall goal to enable the entire industry to further flourish by introducing industry-changing innovations.
From small start-ups to globally operating pharmaceutical companies, Bacthera supports its clients in developing analytical and manufacturing processes of their strains. With their long experience in handling bacteria in DS and DP production, they can offer tailor-made development and large-scale commercial solutions.
NemaLife is a techbio platform company developing AI and microfluidics-based solutions for various industries to reduce R&D costs and the use of mammals in preclinical assays. Its patented low-cost whole organism assays de-risk and accelerate product development by providing actionable data. NemaLife’s technology is built with scalability and versatility in mind, helping innovative companies and academic laboratories accelerate their R&D and scientific discoveries to improve the quality of human life on a healthy planet.
https://www.nemalifeinc.com/probiotics-postbiotics
×Intralytix, Inc. is a privately held, revenue-generating biotechnology company focused on the discovery, production, and marketing of bacteriophage-based products for microbiome modulation, and for controlling bacterial pathogens in various environmental, food processing, and medical settings.
×COSMAX Group is a global no.1 research, development and production business group for cosmetic and health functional food products. (consists of COSMAX, COSMAXNBT, COSMAXBIO)
Across the globe, 600 beauty companies, including 15 of the world’s top 20 beauty companies, are in a partnership with COSMAX.
As a global leader of K-Beauty and a company that develops and manufactures equipment as well as packaging, COSMAX Group are interwoven and focused through each field and integration.
ENG https://cosmax.com/new/en/main.asp
KOR https://cosmax.com/main.asp
CHN https://cosmax.com/new/cn/main.asp
Mbiomics GmbH, founded in 2020, is a privately-owned German biotech start-up with a novel multiplexing approach to precision microbiome diagnostics. Mbiomics’ proprietary hybridization technology complements sequencing-based technologies and addresses the unmet need of microbiome diagnostics by design: scalability from first sample, fast turnover and unprecedented quantitative resolution.
×ADM unlocks the power of nature to enrich the quality of life. We’re a premier global human and animal nutrition company, delivering solutions today with an eye to the future. From the seed of the idea to the outcome of the solution, we give customers an edge in solving the nutritional and sustainability challenges of today and tomorrow.
×Microbiology International specializes in laboratory automation by providing advanced instruments and custom media solutions to the modern laboratory. Our advanced Whitley Workstations provide a strict anaerobic or precisely controlled atmosphere for gut microbiota applications. Features include no-bake catalyst, glove-free operation, maintenance-free humidity control, electronic conditions monitoring, touchscreen interface, transfer airlock, and more. Whatever your application, we can tailor the Whitley Workstation to your requirements. Stop by our booth for a demonstration.
https://800ezmicro.com/
Invitek Molecular offers complete solutions for reliable and validated microbiome sample management, from sample collection and stabilization to manual and automated DNA extraction.
With the Stool Collection Tubes, we offer a versatile tool for gut microbiome analysis, microbiome-associated disease research, nutrigenomics and veterinary studies. For oral microbiome studies, we offer several options for saliva and swab samples.
Our collection and extraction systems guarantee excellent performance in downstream NGS applications.
.
https://www.invitek-molecular.com/products/microbiome.html
ProDigest offers a broad range of contract research services for testing probiotics, LBPs, prebiotics, nutraceutical, food ingredients, APIs and formulations. Using our unique in vitro and ex vivo technology platforms, we simulate the physiology and the microbiome of the healthy and diseased gastrointestinal tract to – for example in the field of probiotics – provide insight in survival, engraftment, impact on the microbiome, efficacy, mechanism of action, targeted release, metabolite production, interaction with the host.
×With the microbiome gaining widespread medical relevance, Rise BioServices is a specialized CDMO supporting development and manufacturing of microbiome-based products. Rise BioServices is at the forefront of microbiome science and, with our technology edge, offers better solutions for clean space manufacturing of novel microbiome-based medicines and products. Utilizing our scientific and regulatory expertise in Live Biotherapeutic Products (LBPs) and other bacterial products, we support emerging and established companies in all aspects of product development and manufacturing.
×Morinaga has been a key global probiotics manufacturer that possesses strong expertise in the research and development of probiotics bifidobacterial strains. Ever since Morinaga started the research on bifidobacteria more than 50 years ago, these amazing microorganisms never cease to amaze us! We have developed a premium line of Human-Residential Bifidobacteria (HRB) probiotic strains that are highly safe, stable, and effective. You can learn more about how our HRB strains work on promoting human health.
• https://morinaga-usa.com/
• https://morinagamilk-ingredients.com/
The family business started over 300 years ago, first as a sake distillery.
Generations later, the current chairman decided to use the knowledge of fermentation to create a product.
After 23 years of intensive research, Dr. Matsuura perfected the formula that combines 53 ingredients which are fermented for over 3 years and 3 months.
Manda started to sell its signature Wellness Superfood from 1984 in Japan.
Phage Consultants is a company specializing in bacteriophage problems troubleshooting and prevention. It was founded in 2007 based on many years of experience in this field of its founder. Company, among other phage prevention- and troubleshooting-related activities, provides RCB, WCB and MCB testing for the presence of virulent phages and inducible prophages, also in strict anaerobes. Most probably, we have the greatest experience in this field on the whole global market.
×
Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximise return on investment.
If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
For further details please contact
Gavin Hambrook
Telephone +44 (0) 1865 849841 or
email [email protected]
Microbiome Research Reports (MRR) is an international peer-reviewed, open-access journal. All articles published by MRR are made freely and permanently accessible online immediately from the date of publication.
The scope of the journal includes investigations of microbiomes present in one or various body compartments of human beings or other animals. Surveys on the establishment of microbial communities as well as on microbe-microbe interactions and microbe-host communication will be considered for publication. The overall aim of MRR is to publish high-quality researches from scientists with a common interest in microbiome/microbiota research in all its multidisciplinary aspects.
×Beneficial Microbes is a peer-reviewed scientific journal with a specific area of focus: the promotion of the science of microbes beneficial to the health and wellbeing of man and animal. The journal contains original research papers and critical reviews in all areas dealing with beneficial microbes in both the small and large intestine, together with opinions, a calendar of forthcoming beneficial microbes-related events, and book reviews. The journal takes a multidisciplinary approach and focuses on a broad spectrum of issues, including safety aspects of pro- & prebiotics, regulatory aspects, mechanisms of action, health benefits for the host, optimal production processes, screening methods, (meta)genomics, proteomics, and metabolomics, host and bacterial physiology, application, and role in health and disease in man and animal. Beneficial Microbes is intended to serve the needs of researchers and professionals from the scientific community and industry, as well as those of policymakers and regulators.
https://www.wageningenacademic.com/loi/bm
×rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions.
Keep up-to-date with the latest microbiology news by getting our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.
Global Engage is a member of ISLA, a body established to accelerate the event industry transition to a sustainable future. As part of this, we are committed to selecting venues with more sustainable practices.
You can read the Hyatt 2030 environmental goals here.
We have reduced waste by replacing printed documentation with an app. Make sure you have it downloaded to your devices in time for the meeting. Get Agorify on Google Play and Apple App Store.
You will have some great food choices while you are with us but now we have worked with the caterer to increase the proportion of plant-based items. We have also built a plan with the venue to avoid waste through how they serve meals and how any leftovers are processed. Our aim is that you have some great meals, whilst with us, but with less environmental impact by the time you leave.
An international meeting does involve travel but where it is practical, please consider more sustainable alternatives to flying. The app will also have a discussion space to arrange ride shares.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.